In accordance with the Declaration of Helsinki, this study received ethics and data sharing approval through respective research ethics boards (The Conjoint Health Research Ethics Board at the University of Calgary; Research Ethics Board Faculty of Medicine, University of Manitoba, and Research Resource Impact Committee of CancerCare Manitoba). All participants signed informed consent.
In Alberta, nurses identified consecutive survivors in their cancer clinic/community/and navigator roles (see Collie et al.1 for details). Survivors’ eligibility criteria included over age 18, English literate, stages I–III, and within 2 weeks (+/−) of end of active treatment regardless of formal oncology discharge status. For bca (n = 36), the study was provincial, including two urban (Calgary and Edmonton) and two rural (Drumheller and Lloydminster) Alberta Health Services (ahs) cancer-centre sites, and one community-based organization (cbo). For hn survivors (n = 21) we included one urban location (Calgary). The CancerBridges multidisciplinary team developed scps for bca and hn survivors differing only in tumour-specific details. Trained nurses delivered scps during consultations with survivors who then completed the cpe-s1. Nurses who delivered scps (N = 8 of 8) and pcps who received them by fax after consultations (N = 22 of 57), completed the cpe-p after consultations.
Manitoba’s nurse-oncologist teams delivered scps during standard clinical consultations to consecutive colorectal cancer (crc) survivors at the time of medical-responsibility- for-care transfer to community family physicians or nurse-practitioners (pcps). We approached survivors in Cancer-Care, Manitoba cancer clinics (Winnipeg) or Winnipeg Regional Health Authority, with those consenting receiving mailed surveys that included the cpe-s and other measures. Eligibility criteria included patients discharged to pcp care, over age 18, English literate, Stage I–III crc, minimum 12-months post-diagnosis, with ct scan demonstrating no evidence of recurrence.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.